Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1575-2025

Abbott Diagnostics Scarborough, Inc. recalls Brand Name: ID NOW Influenza A/B 2 24T Product Name: ID NOW Influenza A/B 2 24T Model/C…

Abbott Diagnostics Scarborough, Inc.Scarborough, ME, United StatesReported Apr 23, 2025 · 1 year ago
Legal News Analyst ·

Reason for recall

the impacted lots have a higher occurrence of invalid rates when compared to the product Instructions for Use.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Brand Name: ID NOW Influenza A/B 2 24T Product Name: ID NOW Influenza A/B 2 24T Model/Catalog Number: 427-000 Software Version: N/A Product Description: Influenza A And Influenza B Multiplex Nucleic Acid Assay; Real Time Nucleic Acid Component: No

Lot / code information

Model
427-000; GTIN/DI 10811877010422
Lot #
000M889669
Model
427-000; GTIN/DI 10811877010422
Lot #
000M890889
Model
427-000; GTIN/DI 10811877010422
Lot #
000M916327
Model
427-000; GTIN/DI 10811877010422
Lot #
000M916649
Model
427-000; GTIN/DI 10811877010422
Lot #
000M916672
Show 48 more code fields
Model
427-000; GTIN/DI 10811877010422
Lot #
000M916724
Model
427-000; GTIN/DI 10811877010422
Lot #
000M917131
Model
427-000; GTIN/DI 10811877010422
Lot #
000M917164
Model
427-000; GTIN/DI 10811877010422
Lot #
000M917180
Model
427-000; GTIN/DI 10811877010422
Lot #
000M917508
Model
427-000; GTIN/DI 10811877010422
Lot #
000M917581
Model
427-000; GTIN/DI 10811877010422
Lot #
000M919907
Model
427-000; GTIN/DI 10811877010422
Lot #
000M921626
Model
427-000; GTIN/DI 10811877010422
Lot #
000M921636
Model
427-000; GTIN/DI 10811877010422
Lot #
000M921728
Model
427-000; GTIN/DI 10811877010422
Lot #
000M923485
Model
427-000; GTIN/DI 10811877010422
Lot #
000M926234
Model
427-000; GTIN/DI 10811877010422
Lot #
000M926370
Model
427-000; GTIN/DI 10811877010422
Lot #
000M927991
Model
427-000; GTIN/DI 10811877010422
Lot #
000M928421
Model
427-000; GTIN/DI 10811877010422
Lot #
000M929248
Model
427-000; GTIN/DI 10811877010422
Lot #
000M931072
Model
427-000; GTIN/DI 10811877010422
Lot #
000M934181
Model
427-000; GTIN/DI 10811877010422
Lot #
000M939117
Model
427-000; GTIN/DI 10811877010422
Lot #
000M939160
Model
427-000; GTIN/DI 10811877010422
Lot #
000M939186
Model
427-000; GTIN/DI 10811877010422
Lot #
000M939468
Model
427-000; GTIN/DI 10811877010422
Lot #
000M939480
Model
427-000; GTIN/DI 10811877010422
Lot #
000M952883

What the firm is doing

On March 4, 2025 PRODUCT REMOVAL NOTICE letters were sent to distributors. Necessary Actions to be Taken by Distributor: 1. If you have impacted inventory held in stock, then: "Immediately quarantine impacted product per your local procedure. "Complete and return the Distributor Acknowledgment Form (Form must be completed, signed and returned to receive replacement product). "Contact Customer Service to arrange return of your product by Abbott. 2. If you have forwarded the product listed above to others within your distribution network, then: "Inform them of this Product Removal Notice and provide to them a copy of this notice and request they take the necessary action. 3. If you have forwarded the impacted product to your customers, then: "Provide customer list to Abbott based on the product information in Appendix II as outlined in the distribution agreement within 48 hours of receipt of this Product Removal Notice. "Abbott will notify customers of this Product Removal Notice. 4. If you do not have any inventory of the impacted lot(s), then: "All product lots not identified in Appendix I can continue to be used. If you have questions regarding this information, U.S. Customers please contact Sedgwick at 1 888 671 8858 (available 8am 6pm EST, Monday - Friday). Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA s MedWatch Adverse Event Reporting program either online (http://www.fda.gov/MedWatch/report.htm), by mail (http://www.fda.gov/MedWatch/getforms.htm), by phone (1-800-332-1088), or by fax (1-800-FDA-0178). If you have experienced any patient or user injury associated with this Removal Notice, please immediately report the event to your local area Customer Service. ****Update 05/08/2025**** On April 29, 2025 Updated PRODUCT REMOVAL NOTICE letters were sent to distributors notifying of additional lots that were included in the recall.

DistributionShow details

US Nationwide distribution.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls